» Articles » PMID: 33869058

Case Report: EBV-Positive Extra-Nodal Marginal Zone Lymphoma Associated With XMEN Disease Caused by A Novel Hemizygous Mutation in

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Apr 19
PMID 33869058
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: X-linked immunodeficiency with magnesium defect and Epstein-Barr virus infection and neoplasia (XMEN) disease is an X-linked genetic disorder of immune system caused by loss-of-function mutation in gene encoding Magnesium transporter 1 (MAGT1). Individuals with XMEN disease are prone to developing Epstein Barr Virus (EBV)-associated lymphomas. Herein, we report the first known case of an EBV+ EMZL associated with XMEN disease.

Case Presentation: The patient was an 8-year-old Chinese boy who suffered from recurrent infections from birth. Six months before, the patient presented with a painless mass on his upper lip and excisional biopsy revealed an EBV-positive extra-nodal marginal zone lymphoma (EBV+ EMZL). Furthermore, molecular investigations with next-generation sequencing identified a novel germline mutation in MAGT1 (c.828_829insAT) in the patient. The c.828_829insAT variant was predicted to cause premature truncation of MAGT1 (p.A277M.fs*11) and consequently was defined as likely pathogenic. The mutation was inherited from his asymptomatic heterozygous carrier mother. Hence the patient was diagnosed with an XMEN disease both clinically and genetically.

Conclusion: Our results expand the genetic spectrum of XMEN disease and also the clinical spectrum of EBV+ EMZL. We highlight the importance of the genetic etiology underlying EBV+ lymphoma in the pediatric population.

Citing Articles

HLH and Recurrent EBV Lymphoma as the presenting manifestation of MAGT1 Deficiency: A Systematic Review of the Expanding Disease Spectrum.

Golloshi K, Mitchell W, Kumar D, Malik S, Parikh S, Aljudi A J Clin Immunol. 2024; 44(7):153.

PMID: 38896122 DOI: 10.1007/s10875-024-01749-y.


Revisiting the immunopathology of congenital disorders of glycosylation: an updated review.

Pascoal C, Francisco R, Mexia P, Pereira B, Granjo P, Coelho H Front Immunol. 2024; 15:1350101.

PMID: 38550576 PMC: 10972870. DOI: 10.3389/fimmu.2024.1350101.


Adult-onset neurodegeneration in XMEN disease.

Benavides D, Ebrahim A, Ravell J, Lenardo M, Gahl W, Toro C J Neuroimmunol. 2023; 386():578251.

PMID: 38041964 PMC: 10842803. DOI: 10.1016/j.jneuroim.2023.578251.


Novel Mutation Found in the First Chinese XMEN in Hong Kong.

Au E, Tung E, Ip R, Li P Case Reports Immunol. 2022; 2022:2390167.

PMID: 35198253 PMC: 8860550. DOI: 10.1155/2022/2390167.

References
1.
Chaigne-Delalande B, Li F, OConnor G, Lukacs M, Jiang P, Zheng L . Mg2+ regulates cytotoxic functions of NK and CD8 T cells in chronic EBV infection through NKG2D. Science. 2013; 341(6142):186-91. PMC: 3894782. DOI: 10.1126/science.1240094. View

2.
Li F, Lenardo M, Chaigne-Delalande B . Loss of MAGT1 abrogates the Mg2+ flux required for T cell signaling and leads to a novel human primary immunodeficiency. Magnes Res. 2011; 24(3):S109-14. PMC: 3732466. DOI: 10.1684/mrh.2011.0286. View

3.
Hoyos-Bachiloglu R, Concha S, Sepulveda P, Campos R, Perez-Mateluna G, King A . The Many Faces of XMEN Disease, Report of Two Patients with Novel Mutations. J Clin Immunol. 2020; 40(2):415-417. DOI: 10.1007/s10875-020-00746-1. View

4.
Gibson S, Swerdlow S, Craig F, Surti U, Cook J, Nalesnik M . EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?. Am J Surg Pathol. 2011; 35(6):807-15. DOI: 10.1097/PAS.0b013e3182190999. View

5.
Li F, Chaigne-Delalande B, Su H, Uzel G, Matthews H, Lenardo M . XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus. Blood. 2014; 123(14):2148-52. PMC: 3975255. DOI: 10.1182/blood-2013-11-538686. View